Adenine and benzimidazole-based mimics of REP-3123 as antibacterial agents against Clostridium difficile and Bacillus anthracis: Design, synthesis and biological evaluation
Tài liệu tham khảo
Antibiotic Resistance Threats in the United States, 2013, Department of Health and Human Services, Centers for Disease Control and Prevention: Atlanta, GA, 2013, 1
Jarrad, 2015, Clostridium difficile drug pipeline: challenges in discovery and development of new agents, J Med Chem, 58, 5164, 10.1021/jm5016846
Bouzianas, 2010, Current and future medical approaches to combat the Anthrax threat, J Med Chem, 53, 4305, 10.1021/jm901024b
Ananthakrishnan, 2001, Clostridium difficile infection: epidemiology, risk factors and management, Nat Rev Gastroenterol Hepatol, 8, 17, 10.1038/nrgastro.2010.190
Miller, 2011, Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals, Infect Control, 32, 387
Levine, 2006, Vancomycin: a history, Clin Infect Dis, 42, S5, 10.1086/491709
Baines, 1978, Metronidazole: its past present and future, J Antimicrob Chemother, 4, 97, 10.1093/jac/4.suppl_C.97
Vardakas, 2012, Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence, Int J Antimicrob Agents, 40, 1, 10.1016/j.ijantimicag.2012.01.004
Wenner, 2004, Anthrax, Dermatol Clin, 22, 247, 10.1016/j.det.2004.03.001
Spencer, 2003, Bacillus anthracis, J Clin Pathol, 56, 182, 10.1136/jcp.56.3.182
Irenge, 2012, Rapid detection methods for Bacillus anthracis in environmental samples: a review, Appl Microbiol Biotechnol, 93, 1411, 10.1007/s00253-011-3845-7
Hicks, 2012, An overview of Anthrax infection including the recently identified form of disease in injection drug users, Intensive Care Med, 38, 1092, 10.1007/s00134-012-2541-0
Critchley, 2009, Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections, J Antimicrob Chemother, 63, 954, 10.1093/jac/dkp041
Citron, 2009, Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria, J Antimicrob Chemother, 63, 972, 10.1093/jac/dkp037
Ochsner, 2009, Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model, J Antimicrob Chemother, 63, 964, 10.1093/jac/dkp042
Eissa A, Blaxland J, Williams R, Metwally K, El-Adl S, Lashine E, Baillie L, Simons C. Targeting methionyl tRNA synthetase: design, synthesis and antibacterial activity against Clostridium difficile of novel 3-biaryl-N-benzylpropan-1-amine derivatives. J Enzyme Inhib Med Chem, in press.
Al-Moubarak, 2011, A homology model for Clostridium difficile methionyl tRNA synthetase: active site analysis and docking interactions, J Mol Model, 17, 1679, 10.1007/s00894-010-0871-9
Evans, 2007, Co-crystal structure of REP3123 bound to Clostridium difficile methionyl tRNA synthetase
http://www.expasy.org.
http://www.ebi.ac.uk.
Pandey, 2010, Silver-guided excimer emission in an adenine-pyrene conjugate: fluorescence lifetime and crystal studies, Inorg Chem, 49, 2020, 10.1021/ic9022008
Shipps G, Cheng C, Achab A, Yao Z, Whitehurst C, Zhang M, Yang X, Herr R, Zych A. Preparation of benzyltetrahydronaphthyridinylethylurea derivatives and analogs for use as HIV blockers. PCT Int Appl WO 2010057101.
Chen, 2006, A 9-vinyladenine-based molecularly imprinted polymeric membrane for the efficient recognition of plant hormone 1H-indole-3-acetic acid, Anal Chim Acta, 569, 58, 10.1016/j.aca.2006.03.062
Hendry, 1993, Preparation of a novel potent inhibitor of methylthioadenosine nucleosidase, Org Bioorg Chem, 10, 1109
Miles, 1938, The estimation of the bactericidal power of the blood, J Hyg, 38, 732, 10.1017/S002217240001158X
Molecular Operating Environment (MOE), 2012.10; Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2012.